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A B S T R A C T
We sought to elucidate how and when the ocular surface ectoderm commits to its differentiation into the corneal
epithelium in eye development from human induced pluripotent stem cells (hiPSCs) under the influence of WNT
signaling and the actions of BMP4. These signals are key drivers ocular surface ectodermal cell fate determi-
nation. It was discovered that secreted frizzled related protein-2 (SFRP2) and Dickkopf1 (DKK1), which are
expressed in neural ectoderm, are both influential in the differentiation of hiPSCs, where they act as canonical
WNT antagonists. BMP4, moreover, was found to simultaneously initiate non-neural ectodermal differentiation
into a corneal epithelial lineage. Combined treatment of hiPSCs with exogenous BMP4 aligned to WNT inhibition
for the initial four days of differentiation increased the ocular surface ectodermal cell population and induced a
corneal epithelial phenotype. Specification of a surface ectodermal lineage and its fate is thus determined by a
fine balance of BMP4 exposure and WNT inhibition in the very earliest stages of human eye development.
1. Introduction
The cornea is the transparent, anterior portion of the eye via which
light enters and is focused towards the retina. The corneal epithelium, a
cellular multi-layer that shrouds the cornea’s outer surface, undergoes
constant cell renewal throughout life and is essential for healthy vision.
The corneal epithelium develops from the ocular surface ectoderm via a
mechanism in which the transcription factor deltaNp63 (p63) is in-
strumental. A well-established ectodermal progenitor marker which
helps determine embryonic epidermal fate and epithelial homeostasis
(Aberdam et al., 2007; Melino et al., 2015; Senoo et al., 2007; Soares
and Zhou, 2018; Yoh and Prywes, 2015), p63 is abundantly expressed
in the basal layers of the corneal epithelium at the limbus (the area at
the edge of the cornea where corneal stem cells reside) and epidermis.
Another ocular surface ectodermal marker, which plays a pivotal role in
regulating optic cup patterning and eye development is paired box 6
(PAX6) (Shaham et al., 2012), and both p63 and PAX6 genes are co-
expressed in the corneal epithelium, acting as critical indicators of
corneal epithelial lineage.
Recently, we described the generation on a laminin 511 substrate of
a two-dimensional colony of hiPSC-derived cells, termed a SEAM (a
self-formed ectodermal autonomous multi-zone) in which cells formed
four distinct concentric zones (Hayashi et al., 2016; Shibata et al.,
2018). In each zone, cells exhibited characteristics of different tissues of
the developing eye; lens, retina cornea, for example. We further devised
a method to isolate and obtain presumptive SEAM-derived corneal
epithelial cells with a cultivation period of 10–12 weeks (Hayashi et al.,
2017).
The current study was conducted to interrogate the mechanisms of
ocular surface ectodermal development using a newly generated p63-
EGFP knock-in hiPSC reporter line (Kobayashi et al., 2017). Ocular
surface ectodermal cells that co-expressed both p63 and PAX6 already
existed in the SEAMs after only 10 days in culture. Here, we show that
inhibition of the WNT signaling pathway and the simultaneous action of
endogenous Bone Morphogenetic Protein 4 (BMP4) in the very earliest
stages of hiPSC differentiation positively influence p63 and PAX6 ex-
pression, and are thus essential drivers for the induction of ocular
surface ectoderm and its differentiation into corneal epithelium.
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2. Material and methods
2.1. Cell line and culture conditions
Generation of the p63-EGFP knock-in hiPSC reporter line was de-
scribed previously (Kobayashi et al., 2017). It was derived from a
human iPSC line, 1383D2, which was used as an experimental control
(WT, wildtype). Cells were cultured in StemFit medium (Ajinomoto,
Tokyo, Japan) on dishes coated with laminin-511E8 (iMatrix-511,
nippi, Tokyo, Japan). Cells were passaged every seven days, changing
the medium every two days (Nakagawa et al., 2014). All experimental
procedures using recombinant DNA were approved by the Recombinant
DNA Committee of Osaka University.
2.2. Differentiation of hiPSCs into ocular ectodermal cells
p63-EGFP knock-in hiPSCs were induced to differentiate into
ocular-like ectodermal cells as part of a SEAM as described in detail
elsewhere (Hayashi et al., 2017, 2016). Briefly, cells were seeded in
dishes pre-coated with laminin-511E8, and grown in StemFit medium
for 8–12 days. To induce ocular differentiation, the StemFit medium
was replaced with differentiation medium (DM) based on Glasgow-
MEM (Thermo Fisher Scientific) supplemented with 10% Knockout
Serum Replacement (Thermo Fisher Scientific), 1 mM sodium pyruvate
(Thermo Fisher Scientific), 0.1 mM non-essential amino acids (Thermo
Fisher Scientific), 2 mM L-glutamine (Thermo Fisher Scientific), 1%
penicillin–streptomycin, and 55 μM monothioglycerol (Wako, Osaka,
Japan). After four weeks, cells were cultured for another four weeks in
corneal differentiation medium (CDM; diluted 1:1 in DM and Cnt-PR
(without EGF and FGF2)) (CELLnTEC Advanced Cell Systems, Bern,
Switzerland) supplemented with 20 ng/mL KGF (Wako), 10 μM Y-
27632 (Wako) and 1% penicillin–streptomycin. Cells were treated with
the respective compounds; BMP4 (1 ng/mL, R&D systems, MN, USA),
IWP2 (1 μM, Wako), CHIR99021 (10 μM, Wako), LDN193189 (10 nM,
Wako), retinoic acid (1 μM, Sigma-Aldrich, St. Louis, MO), SB431542
(10 μM, Wako), rhTGFB2 (10 ng/mL, Wako), JNK-IN-8 (10 μM, Selleck
chemicals, Houston, TX) from day 0 to 4. Cells were treated with the
respective compounds; BMP4 (1 ng/mL), IWP2 (1 μM, Wako) from day
4 to 7. After treatment the medium was changed to DM without the
compounds. Cells treated with DMSO was used as an experimental
control.
2.3. Flow cytometry and cell sorting
p63-EGFP knock-in hiPSCs were differentiated for 10 days or
6 weeks, dissociated with Accutase (Thermo Fisher Scientific) for
60–90 min at 37 °C, harvested through a 40 μm cell strainer (BD
Biosciences, San Diego, CA), and collected into keratinocyte culture
medium (KCM; a 3:1 mix of DMEM without glutamine and Nutrient
Mixture F-12 Ham; Thermo Fisher Scientific) supplemented with 5%
fetal bovine serum (Japan Bio Serum, Hiroshima, Japan), 0.4 μg/mL
hydrocortisone succinate (Wako), 2 nM 3,3′,5-triiodo-l-thyronine so-
dium salt (MP Biomedicals, Santa Ana, CA), 1 nM cholera toxin (List
Biological Laboratory, Campbell, CA), 2.25 μg/mL bovine transferrin
HOLO form (Thermo Fisher Scientific), 2 mM L-glutamine, 0.5% insulin
transferrin selenium (Thermo Fisher Scientific), and 1% penicillin–-
streptomycin. Cells were washed in phosphate-buffered saline. The
1383D2 cell line was used as an EGFP (enhanced green fluorescent
protein) negative control. Cells were sorted on a SH800 Cell Sorter
(Sony Biotechnology Inc., Tokyo, Japan) and the data were analyzed
using SH800 software.
2.4. Cytospin experiments
For immunofluorescence staining, sorted cells were adjusted to a
density of 5–8 × 105 cells/mL, and 200 μL of the cell suspension was
centrifuged at 1000 rpm for 5 min in a Cytospin™ 4 Cytocentrifuge
(Thermo Fisher Scientific). Cells were stained according to the method
for immunofluorescence staining and were counterstained with Hoechst
33342 (Thermo Fisher Scientific) to visualize the nuclei before being
imaged by fluorescence microscopy (Axio Observer. Z1, Carl Zeiss,
Jena, Germany). At least 100 cells were counted in three to six different
images for each experiment, and quantified the ratio of p63+/PAX6+
cells.
2.5. Immunofluorescence staining
Mouse embryonic tissue sections were fixed for 20 min at room
temperature in cold methanol, after which they were washed with Tris-
buffered saline (TBS, Takara Bio, Otsu, Japan) three times for 10 min
each. Cells on slides after cytospin or on 12-well plate were fixed for
20 min at room temperature in 4% paraformaldehyde and similarly
washed. Samples were incubated for 1 h in Tris-buffered saline con-
taining 5% donkey serum (Jackson ImmunoResearch Laboratories, Inc.,
West Grove, PA) and 0.3% Triton X-100 (Wako). They were then
probed overnight at 4 °C with antibodies against p63 (4A4; Santa Cruz
Biotechnology, Santa Cruz, CA) and PAX6 (PRB-278P; Covance
Research Products, Denver, PA) in TBS containing 1% donkey serum
and 0.3% Triton X-100. Subsequently, samples were labeled for 1 h at
room temperature with secondary antibodies conjugated to Alexa Flour
488 and 568 (Thermo Fisher Scientific). Cells were counterstained with
Hoechst 33342 (Thermo Fisher Scientific) to visualize the nuclei, and
imaged by fluorescence microscopy (Axio Observer. Z1, Carl Zeiss,
Jena, Germany).
2.6. qRT-PCR experiments
Differentiated hiPSCs were harvested at specific timepoints and
lysed in QIAzol reagent (Qiagen, Venlo, Netherlands). Total RNA was
extracted and reverse-transcription was performed using the
SuperScript III First-Strand Synthesis System for qRT-PCR (Thermo
Fisher Scientific). Synthesized cDNA was amplified in duplicate on an
ABI Prism 7500 Fast Sequence Detection System (Thermo Fisher
Scientific) using TaqMan Fast Universal PCR Master Mix (Applied
Biosystems). Targets were amplified with TaqMan MGB probes assays
against TaqMan probes (Table S1). Thermocycling conditions for the
TaqMan reactions consisted of an initial cycle at 95 °C for 20 s, followed
by 45 cycles at 95 °C for 3 s and 60 °C for 30 s.
2.7. ELISA analysis
SFRP2 and DKK1 were quantified in cell culture supernatants. The
initial seeding density was 6000 cells per six-well plate. The super-
natant at day 0 was collected at the start of differentiation (i.e. after
10 days of hiPSC culture in StemFit), whereas the supernatants at day 3
were collected after 3 days of differentiation medium (DM) culture.
StemFit and DM were used for internal control, respectively. The
samples were reacted in duplicate or triplicate in a 96-well plate using
the human SFRP2 ELISA kit (Cloud-Clone Corp., Katy, TX) and human
DKK1 ELISA kit (R&D systems) according to the manufacturer’s in-
structions. The activity was measured in a multilabel counter (ARVO
MX, Perkin Elmer, Waltham, MA).
2.8. Blocking assay
p63-EGFP knock-in hiPSCs were incubated with SFRP2 (80.8.6;
Millipore, MA, USA), DKK1 (R&D systems) or mouse IgG2a, kappa
monoclonal (MOPC-173; abcam, Cambridge, U.K), goat IgG polyclonal
(abcam) from 0 to 3 days of differentiation. Cells were analyzed by
FACS and cytospin at 10 days of differentiation. All final concentrations
were adjusted to 100 μg/mL.
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2.9. Statistical analysis
Data are represented as the mean± standard error for each group. n
represents technical replicates. Statistical significance was analyzed via
Wilcoxon rank sum test, steel test, and Steel–Dwass test using JMP ver.
14.0.0 software (SAS institute Japan Co. Ltd., Tokyo, Japan). All sta-
tistical analyzes were conducted with a significance level of α = 0.05
(P < 0.05).
3. Results
3.1. Ocular surface ectoderm expresses p63 and PAX6, and is located in a
paracentral zone at 10 days of differentiation and mouse embryonic eyes
After 6 weeks of differentiation following our previously reported
protocols (Hayashi et al., 2017, 2016), characteristic 4-zone SEAMs
could be formed (Fig. 1A). Earlier in the cultivation period, however,
(i.e. after 10 days of differentiation) p63-EGFP knock-in hiPSCs were
found to have generated an immature pre-SEAM with three zones;
central, paracentral, and peripheral (Fig. 1C, phase contrast), which
emerge from initial colonies of undifferentiated cells (Fig. 1B). Ocular
surface ectoderm that express p63 and PAX6 was confined to the
paracentral zone of the 10-day pre-SEAM as identified by immuno-
fluorescence staining (Fig. 1C), and these were invariably located close
to its inner boundary with the central zone as indicated by white arrows
in Fig. 1D. On the other hand, cells in the central zone were p63 ne-
gative and PAX6 positive due to a neuroectodemal cell fate. In mouse
embryonic eyes at E8.5 and E9.5, p63+/Pax6+ cells were localized
within an area of ocular surface ectoderm. In contrast, the presumptive
lens ectoderm with p63 negative cells at E9.5 was located between the
ocular surface ectoderm with its p63+/Pax6+ cells (Fig. 1E).
3.2. Exogenous BMP4 enhances p63 expression in immature pre-SEAMs
and mature SEAMs in conjunction with WNT inhibition
To establish the molecular mechanisms that underpin surface ec-
todermal commitment, we treated p63-EGFP knock-in hiPSCs with
small molecules and/or growth factors to activate and/or inhibit key
signals involved in eye development. After treatment for the initial
4 days of differentiation in DM (Fig. 1A) p63-enhanced green fluor-
escent protein positive (p63-EGFP+) cells were quantified by FACS in
the immature 3-zone pre-SEAM (at 10 days of differentiation) and the
mature 4-zone SEAM (at 6 weeks of differentiation) (Fig. 2A–D). BMP4
and TGFβ influence epithelial development (Hayashi et al., 2016), and
here we show that cells treated with a BMP4 inhibitor (LDN193189
(LDN)) or a TGFβ inhibitor (SB431542 (SB)) failed to express p63 either
at 10 days or 6 weeks of differentiation. We also discovered that exo-
genous BMP4 increased the number of p63+ cells (1.02-fold at 10 days
of differentiation and 1.48-fold at 6 weeks of differentiation) compared
to DMSO controls, whereas additional TGFβ did not elevate p63 ex-
pression (Fig. 2C and D).
Previous studies have suggested a link between BMP4 and the WNT
signaling pathway in the induction of surface ectoderm during devel-
opment (Patthey et al., 2009), and there are reports of WNT signaling
inhibition disturbing eye development (Fujimura, 2016; Sugiyama
et al., 2013). To determine how WNT signaling contributes to ocular
surface ectodermal commitment, cells were treated with WNT in-
hibitors or a WNT activator. Treatment with WNT signaling inhibitor
IWP2 reveals that p63-EGFP+ cells show 1.2-fold increase at 10 days of
differentiation, and at 6 weeks of differentiation levels show 4.3-fold
increase. IWP2 in combination with BMP4 (Fig. 2 (I + B)) shows 1.5-
fold increase p63 at 10 days of differentiation and 5.1-fold increase p63
at 6 weeks of differentiation. IWP2 plus LDN (Fig. 2 (I + L)), on the
other hand, decreases p63+ cells as expected (0.2-fold at 10 days of
differentiation and 0.49-fold at 6 weeks of differentiation) due to the
suppression of BMP4 signaling (Fig. 2C and D). WNT inhibition,
therefore, is not sufficient to promote the differentiation of hiPSCs into
ocular surface ectoderm in and of itself; BMP4 signaling is required too.
IWP2 acts to block both canonical and non-canonical WNT signaling
pathways owing to the inhibition of WNT secretion and processing.
More specifically, the kinase JNK is involved in the non-canonical
pathway via the activation of cJUN. To examine if JNK signaling and
the non-canonical pathway are involved in surface ectodermal differ-
entiation into a corneal epithelial lineage and p63 expression, we used a
specific JNK signaling inhibitor (JNK-IN-8 (JI8)) to treat p63-EGFP
knock-in hiPSCs for 4 days at the start of DM cultivation (Fig. 1A). The
results showed that JI8-treated cells abundantly expressed p63 after
both 10 days and 6 weeks of differentiation. WNT signaling activation
by GSK inhibitor CHIR99021 (CHIR) during the initial 4 days of dif-
ferentiation completely blocked p63, an outcome that was not miti-
gated by the addition of exogenous BMP4 along with CHIR (Fig. 2
(C + B)). Likewise, LDN and CHIR in combination (Fig. 2 (C + L)) did
not stimulate p63 expression as expected. SEAM formation was grossly
abnormal, with no distinctive zonal formation, when p63-EGFP knock-
in hiPSCs had been treated with CHIR from days 0–4, and this was the
case when BMP4 or LDN had been used too. At 6 weeks of differ-
entiation, p63 was expressed in CHIR treated cells, with and without
BMP4 or LDN, but not in cells at 10 days of differentiation.
To ascertain at what stage in the differentiation process the induc-
tion of ocular surface ectoderm from ectoderm was initiated we treated
cells with IWP2 and/or BMP4, (i) from 0 to 4 days of differentiation and
(ii) from 4 to 7 days of differentiation (Fig. 1A). This revealed that early
(i.e. day 0–4) IWP2 and IWP2/BMP4 treatment resulted in a sig-
nificantly higher differentiation efficiency of p63+/PAX6+ in EGFP+
cells than later (i.e. day 4–7) treatment (Fig. S1), signifying that epi-
thelial induction occurs early in surface ectoderm differentiation.
3.3. Retinoic acid enhances p63 expression in hiPSCs at 10 days, but not at
6 weeks
Retinoic acid (RA) is an essential factor in eye development (Matt
et al., 2005). To investigate the role RA signaling in the development of
the ocular surface ectoderm, p63-EGFP knock-in hiPSCs were treated
with additional RA for the initial 4 days of differentiation in DM
Fig. 1. Schematic description of ocular surface lineage epithelial development and differentiation of p63-EGFP knock-in hiPSCs into early ocular surface
ectoderm. (A) Schematic description of ocular surface ectodermal development in an embryonic eye and a pre-SEAM structure of differentiated human iPSCs at
10 days and a SEAM structure at 6 weeks of differentiation. The cell culture duration, mediums, cell treatments and analysis time points are shown. The cells were
treated 1) from 0 to 4 days with BMP4, LDN 193189 (LDN), TGFβ, SB431542 (SB), retinoic acid (RA), JNK-IN-8 (JI8), IWP2, IWP2 + BMP4 (I + B), IWP2 + LDN
(I + L), CHIR99021 (CHIR), CHIR + BMP4 (C + B), and CHIR + LDN (C + L), or 2) from 4 to 7 days with BMP4, IWP2, or I + B. CE, corneal epithelium; CDM,
Corneal Differentiation Medium; DM, Differentiation Medium; EK, epidermal keratinocyte; CNS, central nervous system; NR, neuroretina; OSE, ocular surface
ectoderm; SE, surface ectoderm; LE, lens; NC, neural crest; OC, optic cup; RPE, retinal pigment epithelium; NE, neural ectoderm. (B) A representative phase contrast
image of a colony of undifferentiated hiPSCs at 0 day (scale bar, 200 μm). (C) Characterization of differentiated p63-EGFP knock-in hiPSCs into ocular cells in the pre-
SEAM structure at 10 days of differentiation (scale bar, 100 μm). Immunofluorescence staining for ocular cells markers; p63 expression (green) was detected in the
paracentral zone and PAX6 expression (red) was detected in the central and paracentral zone. Nuclei, blue. (D) Higher magnification images of highlighted zone from
C. The white arrows indicate p63+/PAX6+ cells in the paracentral zone (scale bar, 100 μm). (E) p63+/Pax6+ cells in mouse embryonic eyes at E8.5 and E9.5 (left
panels; upper and bottom, scale bar, 200 μm and the other pictures, scale bar, 100 μm). p63 (green) and Pax6 (red) in the embryos. Nuclei, blue. The white arrows
indicate p63+/Pax6+ cells. The yellow allows indicate ventral and dorsal. OSE, ocular surface ectoderm; PLE, presumptive lens ectoderm; OV, optic vesicle.
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(Fig. 1A). As seen from the average ratios of p63-EGFP+ cells at
10 days and 6 weeks of differentiation (Fig. 2C and D), RA treatment
dramatically increased p63-EGFP+ cells at 10 days, but not 6 weeks, of
differentiation. Quantitative real-time reverse-transcriptase PCR (qRT-
PCR) results confirmed that p63 expression correlated with the pre-
valence of p63-EGFP+ cells at these time points (Fig. 2E and F). An
evaluation of the morphology of ocular surface ectodermal-like cells in
the immature pre-SEAM and the mature SEAM revealed that if ocular
surface ectodermal-like cells had not developed in the pre-SEAM by
10 days of differentiation, then without exception they did not form in
zone 3 of the mature SEAM at 6 weeks of differentiation (Fig. 2A and B).
3.4. Promoting the induction of ocular surface ectoderm by the inhibition of
WNT signaling and exogenous BMP4 signaling
To assess the proportion of ocular surface ectodermal cells that
express both p63 and PAX6, we isolated p63-EGFP+ cells at 10 days
and 6 weeks of differentiation and quantified the p63+/PAX6+ cell
ratio based on immunostaining characteristics (Fig. 3A and B). This
analysis was not conducted for cells treated with CHIR, CHIR + BMP4,
and CHIR + LDN at 10 days of differentiation, and with SB at 6 weeks
of differentiation because of the previously ascertained negative ex-
pression of p63-EGFP+ cells (Fig. 2C and D). The differentiation effi-
ciency of p63+/PAX6+ cells was determined by assessing the total cell
number, the percentage of p63-EGFP+ cells (ascertained by FACS
analysis), and the PAX6+ cell ratio in EGFP+ cells obtained by the
cytospin method (Fig. 3C, Fig. S3A and S3B). This analysis revealed that
cells treated with IWP2 and/or exogenous BMP4 signaling have a sig-
nificantly enhanced p63+/PAX6+ differentiation efficiency at 10 days
of differentiation, which was further increased by 6 weeks of differ-
entiation. By immunofluorescent staining, zone 3 with its p63+/
PAX6+ cells, was larger following IWP2 and BMP4 treatment com-
pared with non-treated DMSO controls (Fig. 3D).
3.5. Canonical and non-canonical WNT signaling during early
differentiation
To discern the treatment efficiency of the various small molecules
during the initial 4 days of differentiation we examined gene expression
patterns for the WNT (Fig. 4A) and BMP4 signaling pathways (Fig. 4B)
at the end of this period, and confirmed that canonical WNT signaling
genes (WNT1 and WNT3A) were significantly downregulated in IWP2-
treated cells (i.e. IWP2 and I + B) compared to DMSO controls. Ca-
nonical WNT activation was confirmed by the discovery that canonical
WNT target genes such as AXIN2 and LEF1 were elevated in CHIR-
treated cells. WNT inactivation in IWP2-treated cells was confirmed by
the suppression of AXIN2 and LEF1. Additionally, non-canonical WNT
signaling genes (WNT5A and WNT11) were upregulated in CHIR-
treated cells. We also treated cells with JI8 to reduce the levels of JNK
downstream genes such as cJUN. This showed that cJUN gene expres-
sion was considerably reduced by JNK inhibition (Fig. 4A). These re-
sults indicate that IWP2 is effective in inhibiting the canonical WNT
pathway, and CHIR is effective in activating both canonical and non-
canonical WNT pathways. Our experiments also revealed that CHIR-
treated cells had downregulated ID1 expression, whereas BMP4-treated
cells displayed marginally elevated expression. This finding is relevant
because ID1 is one of the major downstream transcriptional targets of
BMP signaling. It is also worth noting that BMP4 is directly upregulated
by OVOL2, and that inhibition of BMP signaling by LDN-treated cells –
along with WNT activation by CHIR-treated cells – downregulated
OVOL2 and p63 expression (Fig. 4B). When we investigated eye de-
velopmental-related gene expression at 10 days of differentiation we
found that CHIR-treated cells failed to express PAX6, SIX3, and RAX as
major regulators of eye development (Fig. S3C–F).
3.6. Initiation of ocular surface ectodermal development by exposing cells to
WNT inhibition and exogenous BMP4 during early stage development
Our initial experiments indicated that ocular surface ectoderm ex-
hibited corneal epithelial commitment (i.e. the cells were p63+/
PAX6+) in the paracentral zone of the immature pre-SEAM at 10 days
of differentiation (Fig. 1C and D). To further probe the likely me-
chanisms at play, the three zones (i.e. central, paracentral, and per-
ipheral) of the pre-SEAM colonies at 10 days of differentiation were
isolated after which the gene expression levels in each zone were ex-
amined (Fig. 5A). This was done to test the hypothesis that WNT in-
hibition is involved in ocular surface ectodermal differentiation in the
early stages of eye development. Major genes involved with WNT sig-
naling inhibition were examined by qRT-PCR (Fig. S4B), and the results
revealed that SFRP2 and DKK1 were substantially expressed amongst all
WNT signaling antagonists. Notably, expression levels of SFRP2, en-
coding a negative regulator of canonical WNT signaling, exhibits si-
milar expression patterns as PAX6. SFRP1, in contrast, revealed no
correlation with PAX6. DKK1, a WNT signaling inhibitor, and BMP4
were marginally more highly expressed in the paracentral zone among
all zones (Fig. 5A), while p63 expression correlated with that of E-
cadherin as a surface ectoderm marker.
To investigate the chronology of p63 and PAX6 expression, cells
from 0 to 14 days of differentiation were analyzed by qPCR. This re-
vealed that SFRP2 and PAX6 were expressed as early as day 0, whereas
p63 expression was not seen until just before day 5 of development.
Conversely, LIN28A, a marker of undifferentiated cells, decreased as
differentiation progressed (Fig. S4A). SFPR2 and DKK1 secretion into
culture medium, quantified by enzyme-linked immunosorbent assay
(ELISA), revealed their presence at 3 days of differentiation (Fig. 5B and
C). DKK1, in particular, was abundant in the culture medium at 3 days
of differentiation. Neutralizing tests for SFRP2 and DKK1 conducted by
blocking the functionality of endogenous, secreted SFRP2 was found to
regulate and inhibit ocular surface ectodermal differentiation. Treat-
ment of cells for the first 3 days of differentiation with a combination of
SFRP2 and DKK1 antibodies was found to partially block autocrine
SFRP2 and DKK1. At the same time, p63 expression was significantly
reduced (Fig. 5D). The number of p63+/PAX6+ cells was considerably
reduced in DKK1-treated cells and SFRP2 Ab and DKK1 Ab-treated cells,
and moderately reduced in SFRP2 Ab-treated cells (Fig. 5E). Blocking
secreted DKK1 by the use of a DKK1 antibody caused elevation of
AXIN2 and LEF1 gene expression following activation of canonical WNT
signaling (WNT1 and WNT3A) (Fig. 5F). Fig. 6B shows a schematic
based on published data (Fujimura, 2016; Giger and Houart, 2018; Li
et al., 2013; Patthey et al., 2009) and the results presented herein, along
Fig. 2. Expression of p63 in surface ectodermal cells differentiated from p63-EGFP knock-in hiPSCs. (A, B) Fluorescence-activated cell sorting (FACS) based on
p63 expression at 10 days and 6 weeks of differentiation. The cells were treated from 0 to 4 days with BMP4, LDN, TGFβ, SB, RA, JI8, IWP2, IWP2+ BMP4 (I + B),
IWP2 + LDN (I + L), CHIR, CHIR + BMP4 (C + B), and CHIR + LDN (C + L). Wild-type (WT) is a negative control for FITC signal. The plots are representative of
samples at 10 days and 6 weeks of differentiation, respectively. The percentage of EGFP in plots indicates an average value. Representative phase contrast images are
at 10 days and 6 weeks of differentiation (scale bar, 100 μm). Observation of ocular surface ectoderm (OSE) at 10 days of differentiation and of SEAM zone 3 at
6 weeks of differentiation are indicated by a plus (+); an absence is noted by a minus (−). (C, D) The average ratio of p63-EGFP population [%] in 10 days and
6 weeks of differentiated cells. (E, F) Gene expression levels of p63 correlated to EGFP positive cells. Data shown as the mean ± SD (n = nine independent
experiments for DMSO, BMP4, IWP2, and I + B, n = six independent experiments for LDN, RA, I + L, CHIR, C + B, and C + L, n = seven independent experiments
for TGFβ, and SB, n = five independent experiments for JI8 at 10 days of differentiation, n = eight independent experiments for DMSO, BMP4, IWP2, and I + B,
n = five independent experiments for LDN, TGFβ, SB, RA, JI8, I + L, CHIR, C + B, and C + L at 6 weeks of differentiation). N.D. Not determined.
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with our interpretation of the information and its fit with mechanisms
of eye development. Of note, is the idea of a differential “head vs trunk”
mode of surface ectodermal differentiation and the emergence of the
ocular surface ectoderm – and subsequently the ocular surface epithe-
lium – via the head, with cell fate determined by the inhibition of ca-
nonical WNT signaling and BMP4.
4. Discussion
Ocular/head surface ectoderm development was studied using a
p63-EGFP knock-in hiPSC reporter line, which allows us to specifically
trace epithelial stem/progenitor cells. BMP4 and the WNT pathway
have been fairly widely studied and are known to be instrumental in
defining ectodermal-epithelial cell fate and in repressing neural fate
(Aberdam et al., 2007; Cruciat and Niehrs, 2013; Groves and LaBonne,
2014; Metallo et al., 2008; Wilson and Hemmati-Brivanlou, 1995). With
Fig. 3. p63/PAX6 differentiation efficiency. (A) Schematic of the experimental protocol for isolation of p63+ cells. The sorted cells were immunostained with
PAX6 (red) followed by cytospin analysis and quantification of the ratio of p63+/PAX6+ in p63+ cells. (B) Immunostaining images of PAX6 positive cells in sorted
p63-EGFP positive cells at 10 days and 6 weeks of differentiation. Nuclei, blue (scale bar, 20 μm). (C) Differentiation efficiency of p63+/PAX6+ cells. The number
was calculated from the relative total cell number × relative EGFP number × relative number of p63+/PAX6+ positive cells. Data shown as the mean ± SD
(n = five independent experiments). *p < 0.05, and **p < 0.01. N.D. Not Determined. A dashed line indicates a normalized value based on DMSO controls. (D)
Immunostaining for ocular cells markers. Co-expression of p63 (green) and PAX6 (red) was detected in the SEAM at 6 weeks of differentiation. Nuclei, blue (scale bar,
100 μm).
Fig. 4. Expression levels of WNT signaling and BMP4 signaling-related markers at 4 days of differentiation. (A) Quantitative gene expression of WNT ligands
and downstream genes; WNT1, WNT3A, AXIN2, LEF1 as markers associated with the canonical pathway, and WNT5A, WNT11, cJUN as markers associated with the
non-canonical pathway. (B) Quantitative gene expression of BMP4 related genes; ID1 is a major downstream transcriptional marker of BMP4, and OVOL2 and p63 are
directly regulated by BMP4 expression. Data shown as the mean ± SD (n = five independent experiments). Asterisk represents statistical differences (*p < 0.05).
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regards to the corneal epithelium, other groups have shown how cor-
neal epithelial progenitors can be induced from iPSCs using BMP4, RA
and, EGF (Kamarudin et al., 2018), or from hPSCs using IWP2, FGF and,
SB431542 (Hongisto et al., 2017; Mikhailova et al., 2014). The latter
was achieved, in part, because of the suppression of neuroectodermal
commitment by the TGFβ signaling inhibitor, SB431542. These and
similar studies allude to cell differentiation into corneal epithelial cells,
but they are indicative rather than definitive and do not specifically
delineate the ocular surface ectodermal cell fate and the differentiation
processes involved. PAX6 single positive cells can differentiate into cells
of the neuron, neural crest, or neural retina (Shaham et al., 2012),
whereas p63 single positive cells can terminally differentiate into any
type of stratified epithelial cells (e.g. corneal epithelium, skin epi-
dermis, or oral mucosal cells) (Barbieri and Pietenpol, 2006; McKeon,
2004; Senoo et al., 2007). Thus, p63 co-stained with PAX6 is needed to
prove that cells are ocular surface ectoderm, and the results presented
here utilize our previously generated p63-EGFP knock-in hiPS cells
(Kobayashi et al., 2017) to do this and indicate that p63+/PAX6+ cells
of an ocular surface ectodermal phenotype are present in the very early
stages of eye development. We also show that autocrine BMP4 signaling
and WNT inhibition during hiPSC differentiation in vitro play funda-
mental roles in the development of ocular surface ectodermal and
epithelial cell lineages.
In order to interrogate the effect of secreted signals during early
differentiation cells were treated with enhancing and/or inhibiting
signals (e.g. WNT signaling, BMP4, TGFβ and additional RA) for the
first 4 days of differentiation, and this clearly revealed that the mor-
phology of the pre-SEAM and SEAM was distinctively different with
various p63 expression patterns. It was notable that the immature pre-
SEAM structures that had formed at 10 days of differentiation were not
able to recover a SEAM-like morphology, even when cultivated for
6 weeks of differentiation (Fig. 2A and B). This suggests that cell fate in
situ is likely determined early in development via WNT inhibition and
BMP4 signaling. Findings from IWP2 and BMP4 treated cells revealed
that within the first 4 days of differentiation is the critical period that
seals the fate of the differentiating cells, and that the period im-
mediately after this (i.e. 4 to 7 days) has no influence on the pattern of
differentiation (Fig. S1A–F).
In mouse embryos, the epiblast at embryonic day (E) 5.5 has plur-
ipotency. Gastrulation begins at E6.5 and surface ectoderm and neural
ectoderm are committed by E7.5 (Li et al., 2013). Ordinarily, devel-
oping mouse eyes are not often studied before the initiation of pre-
sumptive lens invagination at E9.5, but here we conducted im-
munostaining at E8.5, which identifies p63+/Pax6+ cells localized
within an area in which cells are believed to commit to become ocular
surface epithelium (Fig. 1E) (Collomb et al., 2013). Based on the ex-
pression patterns of PAX6 and p63, our findings imply that hiPSCs that
differentiate into ocular surface ectoderm correlate to the E8.5–E9.5
mouse eye at 10–14 days of differentiation (Hayashi et al., 2016).
Previous studies have shown that the loss of PAX6 in developing
corneal epithelial cells results in a conversion to epidermal develop-
ment (Collomb et al., 2013; Ouyang et al., 2014). Here, we show that
cells treated with RA and CHIR express p63, but not PAX6. Moreover,
analysis of the HOX gene expression pattern (Okubo et al., 2018) sug-
gests that p63+ CHIR-treated cells are destined towards trunk epithe-
lial pattering (e.g. feet and legs), whereas the fate of p63+ RA-treated
cells are likely that of the facial epithelia, such as the eyelids, cheek and
neck tissue (Fig. S2). We thus contend that p63 in ocular surface ec-
toderm expresses much earlier than p63 in epidermis. Although RA is a
widely accepted factor for the induction of epidermis via ectoderm
development (Metallo et al., 2008), treatment with RA early in the
expansion of hiPSCs into a SEAM does not result in the development of
the ocular surface ectoderm and the corneal epithelium due to sup-
pression of PAX6.
Other investigators have shown that SFRPs and/or DKK1 co-
ordinately control forebrain development (including the development
of ocular precursors) (Lewis et al., 2008; Mukhopadhyay et al., 2001)
and that a DKK1 ± haploinsufficiency leads to developmental eye
disorders (Giger and Houart, 2018; Lieven and Ruther, 2011). SFRP2,
moreover, is an essential downstream target of PAX6, and plays a sig-
nificant role in the generation of presumptive corneal epithelial cells in
the ocular surface ectoderm during eye development (Shaham et al.,
2012). It is only expressed during early embryonic development (Chen
et al., 2004), regulated by PAX6 (Machon et al., 2010). Our data shows
that the central zone in the pre-SEAMs abundantly expresses SFRP2,
which is followed by PAX6 expression. DKK1, on the other hand, is
expressed throughout all zones, but is especially prominent in the
paracentral zone (Fig. 5A). Thus, we showed the specification of the
ocular surface ectoderm is precisely controlled by WNT/β-catenin in-
hibition through SFRP2 and DKK1 along with exposure to BMP4 sig-
naling. It is also known that the BMP4 signaling dose determines the
direction for neural ectoderm or non-neural ectoderm via WNT sig-
naling mediation (Fujimura, 2016; Leung et al., 2016; Patthey et al.,
2009; Stern, 2005). Simultaneously, BMP4 initiates p63 and E-cadherin
expression in the paracentral and peripheral zones of the pre-SEAM,
thus p63+/E-cadherin+/PAX6+ cells are ocular surface ectoderm and
the paracentral zone is destined to become SEAM zone 3 representing
the ocular surface ectoderm. Of note, our investigations found that in-
hibition of JNK (i.e. non-canonical WNT signaling) increased p63 ex-
pression, but not the amount of corneal epithelial cells. This implies
that canonical WNT inhibition is predominantly involved in early cor-
neal epithelial development. Based on our evidence, a crucial event in
the development of the ocular surface ectoderm is considered to be the
secretion of sufficient SFRP2 via PAX6 expression, as well as the pre-
sence of enough DKK1 for WNT signaling inhibition. Indeed, we found
no significant gene expression changes among other major WNT an-
tagonists (Fig. S4B), and thus conclude that SFRP2 and DKK1-mediated
WNT inhibition are likely instrumental in the formation of the ocular
surface ectoderm. Experiments in which SFRP2 and DKK1 were mildly
blocked by specific antibodies confirmed upregulated WNT1 and
WNT3A by DKK1 neutralization (Fig. 5F), however, at the amounts
used the blocking was not able to influence the function of WNT in-
hibition.
Here, we offer a schematic representation of in vivo and in vitro eye
development in an E8.5 mouse embryo and in hiPSCs after 10 days of
differentiation, respectively. This denotes how WNT inhibition and
Fig. 5. SFRP2 and DKK1 secretion and expression during early differentiation. (A) Gene expression of central, paracentral (para), and peripheral (peri) zones of
a pre-SEAM at 10 days of differentiation (3 to 5 colonies per sample for one experiment, n = five independent experiments). (B)(C) ELISA analysis for SFRP2 or DKK1
secretion in cell culture supernatants. The supernatant at day 0 was collected at the start of differentiation (i.e. after 10 days of hiPSC culture in StemFit), whereas the
supernatants at day 3 were collected after 3 days of differentiation medium (DM) culture (independent experiments; n = four for day 0 and n = four for day 3). (D)
Relative p63-EGFP positive cells population at 10 days of differentiation. The cells were neutralized by endogenously secreted SFRP2 and DKK1 using antibodies
SFRP2 mAb 80.8.6, DKK1 pAb, or SFRP2 mAb + DKK1 pAb, which were added to the wells for 3 days. Mouse IgG2ακ and goat IgG (100 μg/ml) were used for
internal controls (independent experiments; n = five for IgG, DKK1 pAb, and SFRP2 mAb + DKK pAb, n = four for SFRP2 mAb). Data shown as a normalized value
based on DMSO controls. Asterisk represents statistical differences (*p< 0.05) (E) Differentiation efficiency of p63+/PAX6+ cells. The number was calculated from
the relative total cell number × relative EGFP number × relative number of p63+/PAX6+ positive cells. Data shown as the mean ± SD (independent experiments;
n = five for IgG, DKK1 pAb, and SFRP2 mAb + DKK pAb, n = four for SFRP2 mAb). Data shown as a normalized value based on DMSO controls. Asterisk represents
statistical differences (*p < 0.05) (F) Quantitative gene expression of canonical WNT signaling; WNT1 and WNT3A, downstream targeting genes; AXIN2 and LEF1.
Data shown as the mean ± SD (n = three independent experiments).
Y. Kobayashi, et al. Stem Cell Research 46 (2020) 101868
10
Fig. 6. Development of ocular surface ectodermal cell lineages from human induced pluripotent stem cells. (A) Schematic representation of in vivo and in vitro
of eye development with BMP and WNT signaling pathways. The upper diagram shows an early optic vesicle stage at mouse embryonic stage E8.5, whereas the
bottom diagram shows a pre-SEAM structure at 10 days of hiPSC differentiation. Gene expression patterns and cell lineages in the central, paracentral and peripheral
zones in a pre-SEAM correlate to mouse E8.5 are indicated by black arrows based on the results of Fig. 5A. D, dorsal; V, ventral. (B) Schematic image of eye related
organ development. The dotted lines indicate our findings that WNT inhibition and BMP signaling trigger corneal epithelial commitment. The red arrows indicate the
newly proposed signaling pathway.
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BMP4 signaling are involved in the development of the ocular surface
epithelium. The model proposes that the optic vesicle (i.e. neural ec-
toderm) contacts physically with the head surface ectoderm, and that
this is the hallmark event of head surface ectoderm development that
leads to differentiation of the presumptive corneal epithelium and pre-
placodal region by the various inductive signals (Fig. 6A).
5. Conclusions
Our findings demonstrated new aspects about the process of human
eye development by focusing on ocular surface ectodermal cell fate
determination, based upon data acquired from a hiPSC-derived SEAM
model which mimics human eye development. We discovered that
SFRP2 and DKK1 act as putative antagonists of canonical WNT sig-
naling and are both expressed in neural ectoderm in differentiating
hiPSCs. Simultaneously, BMP4 initiates non-neural ectodermal differ-
entiation into a corneal epithelial lineage. We also found that combined
treatment of hiPSCs with exogenous BMP4 aligned to WNT inhibition
for an initial period of 4 days of differentiation significantly increased
the ocular surface ectodermal cell population and induced a corneal
epithelial fate. Our results reveal that ocular surface ectodermal lineage
is controlled by endogenous BMP4 signaling and the inhibition of WNT
signaling at the very earliest stages of hiPSC differentiation (Fig. 6B).
Therefore, we conclude that PAX6 (neural ectodermal marker) initially
determines eye position during gastrulation, and thereafter SFRP2 and
DKK1 mediate WNT signaling inhibition and promote the development
of the ocular surface ectoderm (i.e. p63+/PAX6+ cells). At the same
time, BMP4 is secreted to drive epithelial differentiation as a critical
part of the eye’s development.
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